LNL-012

N/A

Report date: 2025/07/01 15:17:22

Base Information

Drug NameLNL-012

Drug Alias NameLNL-012

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesL&L Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesL&L Biopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A